Dry Age Related Macular Degeneration

Overview of mild, moderate and severe dry AMD including drusen and geographic atrophy.

What are Drusen?

The hallmark of dry AMD is macular drusen (see photo). Drusen are made up of lipids, a type of fatty protein. They may be the result of a failure of the eye to dispose of waste products that are produced when the photoreceptors of the eye drop off older parts of the cell. There are several types of drusen with different levels of risk. Drusen can be small, hard and scattered far apart from each other. They are round and distinct. This type may not create vision problems for a long time and may not even be an indication of macular degeneration. Some drusen can become larger, softer and closer together. Their edges are less distinct. When they get to that stage, there is a greater risk for developing wet macular degeneration and more severe vision loss. They can also disrupt the layers of the retina and may lead to retinal pigment epithelium detachment (PED). Your doctor can see these drusen during a dilated eye exam, even if you are not aware of a vision change. That is one reason why regular eye exams are so important. If you have the larger, soft drusen, your doctor will probably want you to come into the office for check-ups more often. If they do lead to wet macular degeneration, early treatment is essential.

What is Geographic Atrophy?

Geographic atrophy occurs when the photoreceptors (seeing part of the retina) no longer works and the patient develops a blind spot or spot of poor vision in the macula (see photo). Geographic atrophy (GA) is considered the late stage of the dry form of Age-related Macular Degeneration (AMD). It only occurs in about 10 percent of dry AMD patients. GA is usually a sharply delineated round or oval area of hypopigmentation, or apparent absence of the retinal pigment epithelium (RPE), in which choroidal vessels are more visible than in surrounding areas The most common sequence of events leading to GA is the progression of a large drusen to hyperpigmentation, followed by regression of the drusen, hypopigmentation and ultimately RPE cell death, with development of an atrophic area of retina and underlying choriocapillaris, sometimes preceded by the appearance of refractile deposits. This usually takes more than 5 years. Less frequently, GA can follow a drusenoid RPE detachment, regression of a CNV membrane or a RPE rupture. As other forms of late AMD, GA tends to be bilateral (over 50% of cases) and there is high symmetry between eyes for total atrophic area, presence of peripapillary atrophy and enlargement rate. GA often first develops surrounding the fovea, sparing the central area.

What is Progressive Geographic Atrophy?

Geographic atrophy can progress and lead to vision loss. When people with dry AMD lose vision, it is almost always from geographic atrophy. The animated image with this text shows growing geographic atrophy over 3 years in an 86 year old patient. This person is fortunate to have good vision because the dark areas of geographic atrophy are not yet affecting the central vision. Given the progression, the central vision will likely be affected within about 10 years. The images are fundus autofluorescent images that are useful for following geographic atrophy because the atrophy shows up as well delineated dark spots.

What is Pattern Dystrophy?

Pattern dystrophy is a type of dry age-related macular degeneration that involves mostly the very center of the macula. There are several types of pattern dystrophy. The image with this text is of a patient with adult vitelliform macular dystrophy. The image shows the buildup of abnormal deposits under the retina in the center of the macula. Unlike typical dry macular degeneration where the buildup of material is below the retinal pigment epithelium, in pattern dystrophy, the buildup of material is above the pigment epithelium and directly beneath the retina (see asterisks on image). Pattern dysrophy is autosomal dominant, usually presents at a younger age than typical dry AMD, and usually does not progress to wet AMD.

Pattern Dystrophy

What about Diet?

Patients who consume fruits and vegetables have the lowest rates of macular degeneration development. Lutein, a carotenoid pigment found exclusively in fruit and vegetables, serves as the primary protector of the eye. Lutein accumulates in the macula and likely blocks the damage caused by sunlight, one proposed cause of AMD. Fruits and vegetables are also high in antioxidant vitamins such as Beta- carotene, Vitamin E, and Vitamin C. Green leafy vegetables and other colorful foods like kiwi, squash, red grapes, and corn are good sources of Lutein. Other dietary habits have been shown to increase the risk of AMD. Individuals with a higher percentage of vegetable, monounsaturated, and polyunsaturated fats in their diet have higher rates of Wet AMD development. Diets rich in Omega 3 fatty acids reduce the risk of vision loss. These are found naturally in cold-water fish such as salmon and tuna, and in flaxseeds and flaxseed oil. Two servings of fish per week are adequate.

What about Vitamins?

The Age-Related Eye Disease Study 2 showed that among people at high risk for developing late-stage, or wet, macular degeneration (such as those who have large amounts of drusen or who have significant vision loss in at least one eye), taking a dietary supplement of vitamin C, vitamin E, lutein and zeaxanthin, along with zinc, lowered the risk of macular degeneration progressing to advanced stages by at least 25 percent. The supplements did not appear to provide a benefit for people with minimal macular degeneration or people without evidence of the disease during the course of the study. These vitamins contain a mixture of Vitamins C and E, Lutein, Zeaxanthin, Zing and Copper. Another large study in women showed a benefit from taking folic acid and vitamins B6 and B12. It is very important to remember that vitamin supplements are not a cure for macular degeneration, nor will they give you back vision that you may have already lost from the disease. However, these supplements do play a key role in helping some people at high risk for developing advanced (wet) AMD to maintain their vision, or slow down the progression of the disease.

What about Amsler Grid?

One of the first signs of macular degeneration can be wavy, broken or distorted lines OR a blurred or missing area of vision. The Amsler Grid can help you spot these early. Early detection of wet AMD is critical because laser treatment, when indicated, is most successful when performed before damage occurs. Since dry AMD can lead to development of wet AMD, most patients should use the Amsler Grid. Check with your eye doctor to find out how often you should use this test. Wear your reading glasses, if you normally use them and sit about 14 inches away from the screen. Check one eye at a time. Cover the eye you are not testing. Focus on the dark dot in the center of the grid. While looking at this dot, you still should be aware of the lines of the grid. Notice if any of the lines are distorted or broken or if there are blurred areas.

Download Amsler Grid

Dry Macular Degeneration NEWS

Below are current articles from a Google News Feed on Dry Macular Degeneration

Senior Living: Macular degeneration and what it means for you  Long Beach Press Telegram

Loss in vision as you age is common among older adults, but not something you should take lightly or ignore. Problems with your vision can be a sign of a new ...

Review of Neovascular Age-Related Macular Degeneration Treatment Options  AJMC.com Managed Markets Network

Due to an aging population, visual impairment from neovascular age-related macular degeneration (nAMD) is increasing in the United States. Despite ...

A Patient’s Guide to Eye Disease  U.S. News & World Report

Learn about common eye diseases, as well as the symptoms, causes and treatment options, at U.S. News and World Report.

New laser shows promise in treating macular degeneration  WOWT

A breakthrough treatment for macular degeneration is being used on patients in the Rogue Valley. The Medford office using it is believed to be the only one West ...

Reducing the psychological distress of patients diagnosed with a common, retinal disease  EurekAlert

A new study from City, University of London suggests that effective communication from eye health professionals may help reduce patient fears after they are ...

Doc: Yellow lenses to the rescue for macular degeneration  The Detroit News

Age-related macular degeneration is the leading cause of vision loss in industrialized countries.

Cutting Edge Research Grants Announced by The American Macular Degeneration Foundation  Newswise

Vision research foundations combine resources to support macular degeneration investigations with the potential to produce new treatments.

Pixium Vision announced sustained success of its PRIMA System after 12-months in dry age-related macular degeneration patients  GlobeNewswire

Paris, July 18, 2019 – 07:00 AM CEST - Pixium Vision (FR0011950641 - PIX), a bioelectronics company developing innovative bionic vision systems to enable ...

Dry Age-Related Macular Degeneration in the US with Drug Sales - Forecast to 2024  PRNewswire

DUBLIN, July 11, 2019 /PRNewswire/ -- The "US Dry Age-Related Macular Degeneration Market and Competitive Landscape - 2019" report has been added to ...

Age-Related Macular Degeneration (AMD) Market 2019 Diagnosis & Treatment: Highlights by Competitive Scenario with Impact of New Innovations, Size, Share, Segments, Drivers and Challenges With Regional Trends By Forecast to 2023 |  Medgadget

Global Age Related Macular Degeneration Market Research Report Covers Historical Market Trends, Current Market Dynamics, Market Valuation by ...

Global Age-Related Macular Degeneration (AMD) Therapeutics Market 2019-2023 | Development of Gene Therapy for AMD Devices to Boost Growth | Technavio  BioSpace

LONDON--(BUSINESS WIRE)-- The global age-related macular degeneration (AMD) therapeutics market is expected to post a CAGR close to 8% during the ...

Photobiomodulation Device Treats Macular Degeneration - Patient Care  HospiMedica

A novel photobiomodulation (PBM) system uses low-level light to stimulate cellular function in order to treat age-related macular degeneration (AMD).

Age Related Macular Degeneration (AMD) Market 2019 Global Industry Trends, Statistics, Size, Share, Growth Factors, Regional Analysis, Competitive Landscape and Forecast to 2023 |  Medgadget

Age Related Macular Degeneration Market Research Report 2019: Industry Size, Share, Trends, Growth and Opportunity Assessment, Regional Analysis and.

Managed Care Opportunities and Approaches to Supporting Appropriate Selection of Treatment for Sight Prevention  AJMC.com Managed Markets Network

When evaluating the impact of vision-destroying diseases, pharmacologic therapies represent a significant cost to patients, insurance providers, and society.

The American Macular Degeneration Foundation Partners with Fight for Sight to Offer Summer Student Research Fellowships  Newswise

Eye research funders come together to foster research to treat age-related macular degeneration.

Dosing underway in BioTime dry AMD trial  Healio

The first patient has been dosed in an ongoing phase 1/2a clinical trial with a new thaw-and-inject formulation of OpRegen, delivered with the Orbit subretinal ...

Reducing patient fears after dry AMD diagnosis  News-Medical.net

A new study from City, University of London suggests that effective communication from eye health professionals may help reduce patient fears after they are ...

Notal Vision Diagnostic Clinic reports completion of 6 million ForeseeHome AMD home-monitoring tests  GlobeNewswire

Manassas, VA, July 18, 2019 (GLOBE NEWSWIRE) -- Notal Vision, Inc., a company focused on advancing eye care with precision medicine by extending ...

Retinal metabolic and structural alterations in response to aflibercept treatment in neovascular age-related macular degeneration  MD Linx

In this investigation involving 149 eyes, experts aspired to explore whether retinal vascular oxygen saturation and calibres could predict the initial treatment ...

Twelve-week dosing with Aflibercept in the treatment of neovascular ag | OPTH  Dove Medical Press

Twelve-week dosing with Aflibercept in the treatment of neovascular age-related macular degeneration Justus G Garweg1,21Swiss Eye Institute, Rotkreuz, and ...

What Is the Difference Between Wet or Dry Macular Degeneration?  University of Michigan Health System News

Dry macular degeneration occurs when cells of the macula begin to thin and break down. It is characterized by drusen buildup and typically worsens over time.

When it comes to disease, stem cells are a game-changer, scientists say. This is why  Los Angeles Times

Thousands of the world's leading stem cell researchers are convening in Los Angeles this week to discuss the prospects for a future without human disease.

BioTime Initiates Dosing in Phase I/IIa Clinical Study of OpRegen for Treatment of Dry-AMD Utilizing Orbit Subretinal Delivery System  BioSpace

ALAMEDA, Calif.--(BUSINESS WIRE)-- BioTime, Inc. (NYSE American and TASE: BTX), a clinical-stage biotechnology company developing cellular therapies ...

Yellow lenses can help macular degeneration | News, Sports, Jobs  Lewistown Sentinel

DEAR DR. ROACH: I have an elderly friend who's becoming blind from macular degeneration. After hearing of a particularly frustrating event she experienced ...

Survey Finds Retina Specialists Positively Impact Treatment, Patient Journey for People with Macular Degeneration  PRNewswire

PHILADELPHIA, July 8, 2019 /PRNewswire/ -- A new survey from Health Union finds that people with macular degeneration who regularly see a retina or ...

Time Tested Methods To Fight Age Related Macular Degeneration  Anti Aging News

Medical research continues to make advances bringing with it findings from therapies to treat various conditions such as age related eye conditions, this article ...

United States Wet Age-Related Macular Degeneration Market Report 2019: The Pipeline, Epidemiology, Market Valuations, Drugs (Sales & Market Share), and Competitive Landscape Through 2014-2024 - ResearchAndMarkets.com  Business Wire

DUBLIN--(BUSINESS WIRE)--The "US Wet Age-Related Macular Degeneration Market and Competitive Landscape - 2019" report has been added to ...

“It was a tremendous psychological shock”: the emotional impact of dry AMD  AOP

Patients share their stories, from pretending to see constellations during a family stargazing trip to narrowly avoiding a bus hidden in the fog.

Outlook Therapeutics Doses First Patient in the Second Phase 3 Clinical Trial for ONS-5010 in Wet AMD  Yahoo Finance

Full enrollment expected to occur in calendar Q4 2019. CRANBURY, N.J., July 16, 2019 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (OTLK) (the ...

Research to Prevent Blindness and Partners Award $1.2 Million In Grants for Novel AMD Research  Newswise

Research to Prevent Blindness, with its partners, the American Macular Degeneration Foundation (AMDF) and the International Retinal Research Foundation ...

Age Related Macular Degeneration (AMD) Market Opportunity, Demand, recent trends  News By ReportsGO

Age Related Macular Degeneration (AMD) Market Research focuses on the key trends prevailing in the Global Age Related Macular Degeneration (AMD) ...

Biotech Brief: Reports Forecast Continued Rise in Revenues for Diabetic Ulcer Treatment Market  P&T Community

PALM BEACH, Florida, July 22, 2019 /PRNewswire/ -- According to a report from Grand View Research, the global diabetic foot ulcer treatment market size is ...

Age Related Macular Degeneration Drug Market Astonishing Growth with Key Players | Hospitals, Clinics, Other  PortNews24

The latest business intelligence report on Age Related Macular Degeneration Drug Market Research: Global Status & Forecast by Geography, Type ...

What is macular disease, the condition that has stopped Dame Judi Dench from driving?  Yahoo Lifestyle

Macular degeneration is the biggest cause of sight loss in the UK.

Vitamins, new treatments offer hope for people with macular degeneration  nwitimes.com

Macular degeneration is the leading cause of vision loss, affecting more than 10 million Americans — more than cataracts and glaucoma combined.

Helping the elderly cope with low vision  Opelika Observer

By Beth Pinyerd For the. Opelika Observer. One common age-related disability that we see among our elderly population is low vision. Low vision is a reduced ...

A Local Ophthalmologist Uses New Technology to Restore Vision in Patients With Dry Macular Degeneration  Sarasota

In the 1970s TV show, “The Six-Million-Dollar Man,” Steve Austin had, among his many super-human implements, a bionic eye with a tiny telescope to enhance ...

Study Finds Characteristics Likely to Predict Conversion to AMD in Second Eye in Patients Treated With Anti-VEGFs  The Center for Biosimilars

A secondary post hoc analysis of patients who had neovascular age-related macular degeneration (AMD) and were treated with intravitreal aflibercept or ...

Stroke type unrelated to anti-VEGF treatment  Healio

Type of stroke suffered, whether ischemic or hemorrhagic, in patients with retinal disease was not influenced by anti-VEGF treatment, according to a study.

Moorfields study investigates treatment effectiveness for wet AMD  AOP

The publicly-available data set used in the Moorfields Eye Hospital research is the largest single-centre cohort of patients receiving wet AMD treatment in the ...

7 Tips to Stop Macular Degeneration  Healthline

Macular degeneration is one of the leading causes of blindness in the United States. Here's how to keep your vision safe while enjoying the sun this spring ...

What Routine Eye Exams can reveal about Health  The Laconia Daily Sun

Regular eye exams are even more important as people reach senior years. After turning 60, several eye diseases may develop that can permanently affect ...

Breakthrough in identifying new genes in age-related macular degeneration, the leading cause of blindness  Medical Xpress

Fight for Sight funded research published this week in Clinical Epigenetics, has identified new genes linked to the development of age-related macular ...

Ophthalmic Disease Therapeutics Market to reach US$ 47831.3 Mn by 2026, at a CAGR of 6.1% | Fortune Business Insights  GlobeNewswire

Key companies covered in the Ophthalmic Disease Therapeutics Market Research report include Merck & Co., Inc., Novartis AG, F. Hoffmann-La Roche AG, ...

The Basics About Age-Related Macular Degeneration  Next Avenue

Age-related macular degeneration (AMD) causes deterioration of the macula, the part of the eye that provides sharp, clear, straight-ahead vision. As many Here ...

Luminate meets primary endpoint in phase 2 trial for dry AMD  Healio

A treatment candidate for dry age-related macular degeneration met its primary endpoint in a phase 2 study, with 48% of patients gaining at least eight letters of ...

A Streamlined Pathway to Drug Approval  Scientific American

Randomized, placebo-controlled clinical trials have long been the gold standard for drug approval. Patients are assigned to either drug or placebo and the ...

Low-cost retinal scanner could help prevent blindness worldwide: Re-engineered device offers clinically accurate eye scans at a fraction of the cost  Science Daily

Biomedical engineers have developed a low-cost, portable optical coherence tomography (OCT) scanner that promises to bring the vision-saving technology to ...

A mid-Michigan woman with thinning hair needed a boost. A stranger made sure she got one.  Lansing State Journal

Jessie Davis bought a stranger a $400 hair piece at a Lansing wig store.

What you need to know about wet macular degeneration  Medical Xpress

Millions of people deal with age-related macular degeneration as they get older, but many don't understand the difference between types of the condition or ...

Trial will be first in US of Nobel-winning stem cell technique  STAT

The NIH is planning the first U.S. clinical trial using induced pluripotent stem cells, to treat age-related macular degeneration.

Dry (Atrophic) Macular Degeneration Global Clinical Trials Review, H1, 2019  News Exterior

“Dry (Atrophic) Macular Degeneration Global Clinical Trials Review, H1, 2019” provides an overview of Dry (Atrophic) Macular Degeneration clinical trials ...

Do you know all the health benefits of fish oil?  MD Linx

A closer look at some of the powerful health benefits of fish oil.

Dr Miriam Stoppard: New drug brings hope of slowing sight failure  Mirror Online

Experimental drug AXT107 brings hope to those suffering from age and diabetes-related eyesight issues.

Age-Related Macular Degeneration: 5 Things to Know  Medscape

A guide to the latest on this chronic disease, from emerging treatments to the risk factors to be on the lookout for.

Seeing clearly: Know your risk for macular degeneration  Baylor College of Medicine News

Baylor College of Medicine's Dr. Christina Weng discusses what you need to know about macular degeneration.

3 Biotech Stocks That Could Double Your Money  Yahoo Finance

Doubling your money in the stock market really isn't that hard if you don't mind waiting. For example, a sum invested in the S&P 500 six years ago would have ...

Information on total number of voting rights and shares composing the share capital as at June 30th, 2019  GlobeNewswire

Paris, July 1st, 2019 – 6.00PM CET - Pixium Vision (FR0011950641 - PIX), a bioelectronic company developing innovative bionic vision systems to allow ...

Dr. Clodfelter serves community at Mt. Greenwood Eye Professionals  The Beverly Review

For 35 years, Dr. Bradley Clodfelter has served Mt. Greenwood and its surrounding neighborhoods, and he has become a trusted member of many local families ...

Allergan Announces FDA Acceptance of Glaucoma Candidate NDA  Yahoo Finance

Allergan plc AGN announced that the FDA has accepted the new drug application (“NDA”) for its investigational biodegradable implant candidate, Bimatoprost ...

Eye's vulnerability to macular degeneration revealed  Science Daily

Scientists have found significant differences in the shape and biology of the same type of cell taken from different parts of the retina, according to a new study.

What is age-related macular degeneration?  Times Herald-Record

February is Age-Related Macular Degeneration (AMD) Month.Age-related macular degeneration is deterioration of the retina and deeper layers of the eye that ...

Human Trials Could Begin for Macular Degeneration Stem Cell Therapy  MD Magazine

FDA trial approval would make this trial the first ever to test a stem cell-based therapy derived from induced pluripotent stem cells for treating any disease.

Treatment for Wet Age-Related Macular Degeneration Receives Biologics License Application Approval  Pharmacy Times

Officials with the FDA have accepted Novartis' Biologics License Application (BLA) for brolucizumab (RTH258), a humanized single-chain antibody fragment ...

Boosting natural repair could help solve age related macular degeneration  PharmaTimes

Fight for Sight has announced funding for scientists at Queen's University Belfast. - News - PharmaTimes.

Personalized 'eye-in-a-dish' models reveal genetic underpinnings of macular degeneration  Science Daily

Using stem cells derived from six people, researchers recapitulated retinal cells in the lab. This 'eye-in-a-dish' model allowed them to identify genetic variants ...

OliX confident of its age-related macular degeneration treatment's efficacy  Korea Biomedical Review

OliX Pharmaceutical said it plans to submit an investigational new drug application for OLX301A, a dry and wet age-related macular degeneration (AMD) ...

Why you should protect your eyes this summer (even when it's cloudy outside)  Telegraph.co.uk

In the last two decades we've become more sun savvy than every before, with sales of sun scream soaring.

Take steps to prevent vision loss from macular degeneration  Buffalo News

By Judith Whitehead – Contributing Writer Age-related macular degeneration is the leading cause of blindness among older Americans but treatments have ...

8 More Big Pharma Events in 2019 You Don't Want to Miss  The Motley Fool

These are the clinical trial readouts, FDA decisions, and blockbuster-drug launches that will set the tone for the entire industry.

NIH awards Emory research team $3.2 million to study eye disease in Ebola survivors  Emory News Center

The Emory Eye Center has been awarded a grant from the National Eye Institute, National Institutes of Health (NIH) to further study vision-related issues in Ebola ...

7 Healthy Habits to Help Prevent Macular Degeneration  University of Michigan Health System News

AMD affects the eyesight of millions. A Michigan Medicine specialist offers easy ways to help slow or prevent the disease.

LumiThera Announces First Patient Enrollment in the European Multi-Center, LIGHTSITE II Clinical Study to Treat Dry Age-Related Macular Degeneration  BioSpace

Published: Apr 11, 2019. SEATTLE, April 11, 2019 /PRNewswire/ -- LumiThera Inc., a commercial stage medical device company delivering photobiomodulation ...

Surgeons perform first gene therapy procedure aimed at stopping AMD-related blindness  Healio

Researchers have completed the first gene therapy procedure aimed at stopping age-related macular degeneration.The operation was performed at John ...

Fresh insights into genes and macular degeneration could open new treatment pathways  FierceBiotech

NIH researchers have pinpointed 6 genomic regions that are closely associated with the development of age-related macular degeneration. (Pixabay).

Belite Bio to trial new therapy for macular degeneration  Drug Development Technology

Belite Bio has received the US FDA approval to conduct a Phase I clinical trial of LBS-008 to treat dry macular degeneration and Stargardt disease.

Sunglasses That Help Your Eyes as Well as Your Look  The New York Times

Lenses that transition in sunlight to become sunglasses help protect eyes from dust, bugs, drying breezes and, most important of all, the damaging effects of ...

7 Macular Degeneration Risk Factors You Can Control—and 4 You Can't  Reader's Digest

Your chances of getting this top cause of vision loss in people age 60 and older—depends on both your genetics and your lifestyle.

Novartis' crizanlizumab wins speedy FDA review, putting it closer to blockbuster sickle cell launch  FiercePharma

The FDA has put crizanlizumab, a sickle cell disease candidate that carries blockbuster potential for developer Novartis, under priority review. (Novartis).

Technological advances, preventable strategies can help manage age-related macular degeneration  Reading Eagle

Age-related macular degeneration, or AMD, has long been a scourge for many people as they age.

Diabetic woman is addicted to mangoes | News  Jamaica Star Online

Dear Readers, A reader who is diabetic asks Check Up about the consumption of mangoes at this time. She is a 'mango addict', and the mango crop is very ...

Stem Cell Therapy Patch for Macular Degeneration Sees the Light of Day  Genetic Engineering & Biotechnology News

If approved, the first ever clinical trail to test a stem cell-based therapy may provide a cure for age-related macular degeneration.

FLUID Study Rethinks Treat-and-Extend in Neovascular AMD  Medscape

Study results show that some subretinal fluid can be tolerated after anti-VEGF injections without sacrificing visual outcomes. Dr Charles Wykoff explains why it ...

The Inconsistent Treatment of Biosimilars in Medicare and Medicaid - AAF  American Action Forum

Tara O'Neill Hayes explains how and why Medicare and Medicaid sometimes treat biosimilars as generics -- and sometimes don't.

OpRegen shows positive phase 1/2a study results for dry AMD  Healio

CHICAGO — OpRegen, a retinal pigment epithelium cell therapy transplant for dry age-related macular degeneration, has shown signs of improving the retina ...

AMD Monitoring Comes Home: The Promise of Remote Tech  Medscape

Age-related macular degeneration (AMD) is the leading cause of severe vision loss in older Americans. AMD is a degenerative disease that affects the macula, ...

Age-related macular degeneration may be reduced by artificial intelligence  Health Europa

Action Against AMD have partnered with artificial intelligence company BenevolentAI to uncover the mysteries of age-related macular degeneration.

Researchers are one step closer to developing eye drops to treat age-related macular degeneration  Medical Xpress

Scientists at the University of Birmingham are one step closer to developing an eye drop that could revolutionise treatment for age-related macular degeneration ...

Improving the Burden of Treatment for Age-related Macular Degeneration Through Advances in Delivery  Healio

Learning Objectives: Upon successful completion of this activity, participants should be better able to: Review the evidence regarding the visual effects of ...

Blindness: Macular Degeneration Implant Treatment  Healthline

Researchers say the implant process could eventually be a treatment for the loss of eyesight experienced by millions as they grow older.

Hope for new macular degeneration treatments buoys patients  The Boston Globe

Sean Teare, a 48-year-old health care consultant from Duxbury, struggled to read menus in dimly lit restaurants. After a battery of tests, his optometrist told him ...

LumiThera receives $2.5 million grant to study dry AMD treatment option  Healio

LumiThera has received a $2.5 million small business innovative research phase II grant from the National Institute of Health and the National Eye Institute to ...

Age Related Macular Degeneration 2019 Global Market Size, Share, Emerging Trends, Sales Revenue, Key Players Analysis, Opportunity Assessment and Regional Forecast to 2023 |  Medgadget

As per the study offered by Market Research Future (MRFR), the global age related macular degeneration market is set to expand at a CAGR of 8.3% during.

Be aware of age-related macular degeneration  thebellvillestar.com

COLUMBUS — Age-related macular degeneration (AMD), is a leading cause of vision loss for Americans age 50 and older. The eye disease causes damage to.

How to spot age-related macular degeneration  The Guardian

Every day in the UK, nearly 200 people develop a condition that can lead to visual impairment or even blindness. How do you identify the symptoms and what's ...

Stem Cells Show Promise For Macular Degeneration A new stem cell transplant might help preserve or  WebMD

A new stem cell transplant might help preserve or even restore vision being lost to the dry form of age-related macular degeneration.

Gemini to initiate CLARITY dry AMD disease registry and study  Healio

Gemini Therapeutics announced a disease registry and natural history study to identify and characterize disease progression in patients with non-central ...

Fewer Injections With New Wet Macular Degeneration Therapies  Medscape

New treatments in development — including gene therapy — will likely mean fewer injections for patients with neovascular age-related macular degeneration, ...

Revolutionary eye drops to treat age-related macular degeneration  Drug Target Review

Revolutionary eye drops to treat age-related macular degeneration - developing an eye drop that could revolutionise treatment for AMD.

Aged-related macular degeneration is incurable but preventable  New Jersey 101.5 FM Radio

Aged-related macular degeneration is the top cause of blindness in people age 50 and older.

» Load more

What about Resources?

Dr. Pautler's Blog
American Academy of Ophthalmology
MedlinePlus
National Institutes of Health
  • ARMD
    NIH's SeniorHealth website covers the topic of Age-Related Macular Degeneration
National Eye Institute
American Foundation for the Blind - Senior Site
  • Macular Degeneration
    Basic information about AMD and low vision; includes a self-test using an Amsler Grid
Journal of the American Medical Association (JAMA)
WebMD
LightHouse International
  • Macular Degeneration
    Provides a general overview of the basics of AMD, and a simulation showing a scene as it might be viewed by a person with AMD
Prevent Blindness America